A state network means more Iowans can seek care for cancer closer to home as research ramps up, write Mark Burkard, Mary Charlton and Bradley Hiatt.

Researchers at Northwestern Medicine found that 65% of their lung cancer patients weren't eligible for screening. They were ...

A community-based (real-world) study showed that artificial intelligence (AI)-informed analysis of screening mammograms ...

Findings expand Telomir-1's oncology profile into cancers of the blood, adding to previously reported activity in ...

In many aspects of our lives, we find meaning in the order in which events occur. We buy into myths about "middle child ...

Osvyrti and Jubereq are FDA-approved denosumab biosimilars for osteoporosis and cancer-related skeletal events, ...

For more information about Syncromune®, Inc. please visit www.syncromune.com.

After a year of heightened expectations over the promise of drugs that co-target PD-1 and VEGF, some important mid- and late-stage datasets are emerging at the annual World Conference on Lung Cancer ...

Researchers discovered that chronic inflammation fundamentally remodels the bone marrow, allowing mutated stem cell clones to ...

Blood cancers such as leukemia are caused by genetic changes in the blood-forming stem cells of the bone marrow. Scientists ...

Stage 1 osteosarcoma is usually localized and has not spread to nearby lymph nodes or distant organs. Early-stage disease is ...

A new study from the Icahn School of Medicine at Mount Sinai helps explain why some people with multiple myeloma, a type of ...